Anzeige
Mehr »
Login
Sonntag, 05.05.2024 Börsentäglich über 12.000 News von 685 internationalen Medien
Cannabisaktien sollten nun den S&P um 60% outperformen!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

GlobeNewswire (Europe)-Archiv vom 19.03.2024

ZeitNachrichten
Sprache: Alle DE EN
LeserMedien
19.03.XOMA Corporation: XOMA Announces Calculation of Additional Price Per Share and Extension of Expiration Date for Tender Offer for Kinnate Biopharma Inc.55EMERYVILLE, Calif., March 19, 2024 (GLOBE NEWSWIRE) -- As previously announced on February 16, 2024, XOMA Corporation ("XOMA" or the "Company"; Nasdaq: XOMA) entered into a merger agreement to acquire...
► Artikel lesen
19.03.Steppe Gold Ltd. Announce Extension of Binding Term Sheet469ULAANBAATAR, Mongolia, March 19, 2024 (GLOBE NEWSWIRE) -- Steppe Gold Ltd. (TSX: STGO) (OTCQX: STPGF) (FSE: 2J9) ("Steppe Gold") is pleased to announce the extension (the"Extension Letter Agreement")...
► Artikel lesen
19.03.Silver Mountain Resources Inc.: Silver Mountain Files NI 43-101 Technical Report for Previously Announced Updated Mineral Resource Estimate at the Reliquias Project28NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN OR INTO THE UNITED STATES TORONTO, March 19, 2024 (GLOBE NEWSWIRE) -- Silver Mountain Resources Inc. ("Silver Mountain"or the"Company")...
► Artikel lesen
19.03.SEALSQ Corp Showcases Its All-In-One Solution for Consumer IoT Device Makers to Achieve New Product Security Verified Mark During the Connectivity Standards Alliance (CSA) Event in Singapore66Geneva, Switzerland, March 19, 2024 (GLOBE NEWSWIRE) -- SEALSQ Corp (Nasdaq: LAES) ("SEALSQ"or"Company"), a leader in semiconductor, PKI, and Post-Quantum technology development, today announced...
► Artikel lesen
19.03.Dominion Lending Centres Inc.: DLC Releases Annual 2023 Results; Achieves Annual Funded Volumes of $56.5 Billion92VANCOUVER, British Columbia, March 19, 2024 (GLOBE NEWSWIRE) -- Dominion Lending Centres Inc. (TSX:DLCG) ("DLCG"or the"Corporation") is pleased to report its financial results for the three months...
► Artikel lesen
19.03.Amcomri Entertainment Inc.: Amcomri Applies for Management Cease Trade Order58VANCOUVER, British Columbia, March 19, 2024 (GLOBE NEWSWIRE) -- Amcomri Entertainment Inc. (the"Company") (Cboe CA: AMEN) (Frankfurt: 25YO) (OTC: AMNNF) announces that it has applied to the British...
► Artikel lesen
19.03.Keyarch Acquisition Corp.: Keyarch Acquisition Corporation Announces Extraordinary General Meeting of Shareholders to Vote on Proposed Business Combination With Zooz Power Ltd.; Form F-4 Declared Effective37NEW YORK, N.Y., March 19, 2024 (GLOBE NEWSWIRE) -- Keyarch Acquisition Corporation (Nasdaq:KYCH) ("Keyarch"or the"Company"), a special purpose acquisition company, and ZOOZ Power Ltd. ("ZOOZ"), a...
► Artikel lesen
19.03.Stellantis N.V.: Stellantis and California Partner to Drive Carbon Emissions Reduction Efforts10Stellantis and California Partner to Drive Carbon Emissions Reduction Efforts Agreement will avoid 10-12 million metric tons of greenhouse gases in the United StatesCustomers across the U.S. will...
► Artikel lesen
19.03.AEON Biopharma Announces Clinical Update and Productive End-of-Phase 2 Meeting with FDA on ABP-450 (prabotulinumtoxinA) for the Preventive Treatment of Migraine35- FDA and AEON align on the design and endpoints for the proposed pivotal Phase 3 trials for the preventive treatment of both episodic and chronic migraine - - An interim analysis from the ongoing...
► Artikel lesen
19.03.AEON Biopharma Announces $15 Million Financing Transaction and Termination of Forward Purchase Agreements206-- Termination of the Forward Purchase Agreements simplifies AEON's capitalization structure -- -- AEON to expand its Board of Directors with appointment of candidate selected by its strategic partner...
► Artikel lesen
19.03.Tempest Therapeutics: Tempest Reports Year End 2023 Financial Results and Provides Business Update125Announced positive randomized first-line HCC data showing superiority of TPST-1120 combination therapy across multiple study endpoints compared to standard of careReported new biomarker data in two...
► Artikel lesen
19.03.Bridger Aerospace Group Holdings, Inc.: Bridger Aerospace Announces Record 2023 Results; Provides Outlook for 2024 Growth123BELGRADE, Mont., March 19, 2024 (GLOBE NEWSWIRE) -- Bridger Aerospace Group Holdings, Inc. ("Bridger", "the Company" or "Bridger Aerospace"), (NASDAQ: BAER, BAERW), one of the nation's largest aerial...
► Artikel lesen
19.03.GDEV Inc.: GDEV announces preliminary unaudited results for the fourth quarter and full year 2023158LIMASSOL, Cyprus, March 19, 2024 (GLOBE NEWSWIRE) -- GDEV Inc. (NASDAQ: GDEV), an international gaming and entertainment company ("GDEV" or the "Company") released its preliminary unaudited financial...
► Artikel lesen
19.03.Sportsman's Warehouse Holdings, Inc.: Sportsman's Warehouse Announces New Executive Leadership94Krischelle Tennessen appointed Chief Human Resources Officer Michael Simpson joins the Company as the new Chief Information Officer WEST JORDAN, Utah, March 19, 2024 (GLOBE NEWSWIRE) -- Sportsman's...
► Artikel lesen
19.03.Cyclacel Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update41- On Track to Start Oral Fadraciclib Phase 2 Proof of Concept in 1H 2024 - - Expect to Report Final Data from Fadraciclib 065-101 Dose Escalation - - Oral Plogosertib Preclinical Data Support Precision...
► Artikel lesen
19.03.Terawulf Inc.: TeraWulf Reports Fourth Quarter and Full Year 2023 Results181Annual Revenue Grows 360% Year-Over-Year; Annual BTC Self-Mined Increases 550% to 3,407 Reports Realized Cost of Power of 3.2 Cents Per Kilowatt Hour in 2023, Outperforming Company Guidance of...
► Artikel lesen
19.03.Corvus Pharmaceuticals, Inc.: Corvus Pharmaceuticals Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results135Soquelitinib advancing towards initial enrollment for registrational Phase 3 clinical trial for PTCL and randomized Phase 1 clinical trial for atopic dermatitis Orphan drug designation and new interim...
► Artikel lesen
19.03.Design Therapeutics, Inc.: Design Therapeutics Outlines Progress Across GeneTAC Platform and Announces Fourth Quarter and Full Year 2023 Financial Results34New Drug Product for Friedreich Ataxia (FA) DT-216P2 with Favorable Nonclinical Pharmacokinetic and Injection Site Safety Profile; Complete GLP Studies by Year-end 2024 to Start Patient Trials in...
► Artikel lesen
19.03.Taysha Gene Therapies, Inc.: Taysha Gene Therapies Reports Full Year 2023 Financial Results and Provides Corporate and Clinical Updates32Data from first adult patient in REVEAL Phase 1/2 trial showed TSHA-102 (low dose, 5.7x1014 total vg) was well-tolerated with no treatment-emergent SAEs as of 35-week assessment, with sustained improvement...
► Artikel lesen
19.03.HealthEquity, Inc.: HealthEquity Reports Fiscal Year and Fourth Quarter Ended January 31, 2024 Financial Results52Highlights of the fiscal year include: Revenue of $999.6 million, an increase of 16% compared to $861.7 million in FY23.Net income of $55.7 million, compared to net loss of $26.1 million in FY23,...
► Artikel lesen
Seite:  Weiter >>